Listed below is a selection of recent publications from the Sather Lab.
A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning. Carbonetti S, Oliver BG, Vigdorovich V, Dambrauskas N, Sack B, Bergl E, Kappe SHI, Sather DN. J Immunol Methods. 2017 Sep;448:66-73.
In vivo cleavage specificity of Trypanosoma brucei editosome endonucleases. Carnes J, McDermott S, Anupama A, Oliver BG, Sather DN, Stuart K. Nucleic Acids Res. 2017 May 5;45(8):4667-4686.
Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection. Sack B, Kappe SH, Sather DN. Expert Rev Vaccines. 2017 May;16(5):403-414.
Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencing. Vigdorovich V, Oliver BG, Carbonetti S, Dambrauskas N, Lange MD, Yacoob C, Leahy W, Callahan J, Stamatatos L, Sather DN. Clin Transl Immunology. 2016 Jul 22;5(7):e93.
Achieving potent autologous neutralizing antibody responses against tier 2 HIV-1 viruses by strategic selection of envelope immunogens. Hessell AJ, Malherbe DC, Pissani F, … Sather DN, Haigwood NL. J Immunol. 2016 Apr 1;196(7):3064-78.
Malaria parasites target the hepatocyte receptor EphA2 for successful host infection. Kaushansky A, Douglass AN, Arang N, Vigdorovich V, Dambrauskas N, Kain HS, Austin LS, Sather DN, Kappe SH. Science. 2015 Nov 27;350(6264):1089-92
Plasmodium falciparum adhesion domains linked to severe malaria differ in blockade of endothelial protein C receptor. Sampath S, Brazier AJ, Avril M, Bernabeu M, Vigdorovich V, Mascarenhas A, Gomes E, Sather DN, Esmon CT, Smith JD. Cell Microbiol. 2015 Dec;17(12):1868-82.
Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria. Keitany GJ, Sack B, Smithers H, Chen L, Jang IK, Sebastian L, Gupta M, Sather DN, Vignali M, Vaughan AM, Kappe SH, Wang R. Infect Immun. 2014 Dec;82(12):5143-53
Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1. Sather DN, Carbonetti S, et al. J Virol. 2014 Nov;88(22):12968-81